Filing Details

Accession Number:
0000899243-20-005000
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-19 06:05:18
Reporting Period:
2020-02-13
Accepted Time:
2020-02-19 06:05:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1731831 Eidos Therapeutics Inc. EIDX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1655016 C Jonathan Fox C/O Eidos Therapeutics, Inc.
101 Montgomery Street, Suite 2000
San Francisco CA 94104
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-02-04 1,632 $0.00 428,625 No 5 G Indirect See footnote
Common Stock Disposition 2020-02-13 10,000 $54.00 418,625 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Indirect See footnote
No 4 S Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,850 Direct
Footnotes
  1. The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014.